ASO Drug Targets ALS and FTD Neuronal Hyperexcitability
ASO Drug Targets ALS and FTD Neuronal Hyperexcitability Northwestern researchers found a way to calm overactive neurons and restore neuronal activity, potentially slowing disease progressi…
ASO Drug Targets ALS and FTD Neuronal Hyperexcitability Northwestern researchers found a way to calm overactive neurons and restore neuronal activity, potentially slowing disease progressi…
FTSE Rises Ahead of BoE Decision London stocks opened higher on Monday, with the FTSE 100 climbing 0.2% to 9,738.46, as investors await a …
Idli Kadai Review Tamil star-actor Dhanush plays a young culturally conflicted son of a rustic Idli maker who returns to his roots after h…
Solar Foods to Develop Solein Production Technology for International Space Station Solar Foods Oyj has signed a contract with OHB System …
Nexus International Targets $5B Revenue and March 2027 IPO Nexus International, led by Founder and CEO Gurhan Kiziloz, is taking a unique …
Arc Raiders Roadmap Shows Promise Embark Studios has revealed its 2025 roadmap for Arc Raiders, promising multiple additions throughout th…
Latitude Festival Lineup Announcement Latitude Festival has revealed its landmark lineup for the 20th edition, featuring a UK festival exc…
Balancer's $70 Million Breach Exposes DeFi's Fragile Foundation A suspected $70 million exploit has hit Balancer, a leading decentralized …
Substance Dependency and Employment According to an evaluation published on 30 October, one in five people (21%) with substance dependenci…
A Giant Hole in the Ocean Hides a Terrifying Truth The Great Blue Hole, located off the coast of Belize, is one of the world's most peculi…
ASO Drug Targets ALS and FTD Neuronal Hyperexcitability Northwestern researchers found a way to calm overactive neurons and restore neuron…